Advanced Biomed Inc. Common Stock
ADVB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $10 | $15 | $78 | $73 |
| - Cash | $3 | $0 | $0 | $3 |
| + Debt | $0 | $0 | $0 | $2 |
| Enterprise Value | $7 | $15 | $78 | $72 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -12.1% | – | – |
| EBITDA | -$0 | -$0 | -$1 | -$0 |
| % Margin | – | -120.1% | – | – |
| Net Income | -$0 | -$0 | -$1 | -$1 |
| % Margin | – | -132.2% | – | – |
| EPS Diluted | -0.001 | -0.001 | -0.069 | -0.045 |
| % Growth | 45.5% | 98.4% | -52% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$1 |
| Capital Expenditures | -$0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$1 |